Endocrinology

Help Shape the Future of Denosumab Treatment

As biosimilars enter the denosumab landscape, your perspective as a healthcare provider is critical in understanding what factors influence treatment decisions. This brief survey explores your views on reimbursement considerations, coding challenges, switching comfort, and drivers of biosimilar choice. As a thank you, by completing the survey, you’ll be entered into a drawing for a chance to win a $200 gift card.

Take the survey now and make your voice heard

Latest News

Phase 3 Data Support Oral Orforglipron for Weight Maintenance After GLP-1–Based Weight Loss
Phase 3 Data Support Oral Orforglipron for Weight Maintenance After GLP-1–Based Weight Loss

December 19th 2025

Topline Phase 3 ATTAIN-MAINTAIN data show oral orforglipron met primary and key secondary endpoints for weight maintenance after prior GLP-1–based injectable therapy in adults with obesity.

 Large National Claims Analysis Underscores Gap Between CGM Eligibility and Real-World Use in Diabetes Care / image credit ©yurii/stock.adobe.com
Large National Claims Analysis Underscores Gap Between CGM Eligibility and Real-World Use in Diabetes Care

December 15th 2025

Perimenopause Misdiagnosis Remains Widespread as Clinicians Miss Hormonal Transition Explains Bruce Dorr, MD, URPS, IFM-CP
Perimenopause Misdiagnosis Remains Widespread as Clinicians Miss Hormonal Transition Explains Bruce Dorr, MD, URPS, IFM-CP

December 9th 2025

ADA Publishes 2026 Standards of Care With Updates to Sections on Technology, Obesity, Cardiometabolic Disease Management / image credit Rita R Kalyani, MD, MHS   Courtesy of the American Diabetes Assocation
ADA Publishes 2026 Standards of Care With Updates to Sections on Technology, Obesity, Cardiometabolic Disease Management

December 9th 2025

FDA Clears Omnipod 5 Algorithm Updates, Adding 100 mg/dL Target Glucose Option / image credit ©Tada Images/stock.adobe.com
FDA Clears Omnipod 5 Algorithm Updates, Adding 100 mg/dL Target Glucose Option

December 4th 2025

Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.